Cellyan Biotechnology Co., Ltd Current Financial Assets At Fair Value Through Profit Or Loss
Cellyan Biotechnology Co., Ltd (HKPD) had Current Financial Assets At Fair Value Through Profit Or Loss of $2.29 million as of 2025-09-30, per its 6-K filed 2026-03-18.
Financial Statements › Notes
ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss · last filed 2026-03-18
- 2025-09-30: Current Financial Assets At Fair Value Through Profit Or Loss $2.29M.
- 2025-03-31: Current Financial Assets At Fair Value Through Profit Or Loss $2.26M.
| Period end | Current Financial Assets At Fair Value Through Profit Or Loss |
|---|---|
| 2025-09-30 | $2.29M 6-K · filed 2026-03-18 |
| 2025-03-31 | $2.26M 6-K · filed 2026-03-18 |